Brain News and Research

RSS

The human brain is the center of the human nervous system and is a highly complex organ. Enclosed in the cranium, it has the same general structure as the brains of other mammals, but is over three times as large as the brain of a typical mammal with an equivalent body size.

ICREA researcher updates latest findings in applied epigenetics

The research team led by Manel Esteller, director of the Cancer Epigenetics and Biology Program at the Bellvitge Biomedical Research Institute (IDIBELL), professor of genetics at the University of Barcelona and ICREA researcher, has updated the latest findings in applied epigenetics in a review paper published in Nature Reviews Genetics.

13 Sep 2012

NDC to advance study and treatment of Alzheimer's and other neurodegenerative diseases

The Neurodegeneration Consortium (NDC), a transformative multi-institutional initiative, will advance the study and treatment of Alzheimer's and other neurodegenerative diseases, thanks to an inaugural $25 million gift from the Robert A. and Renee E. Belfer Family Foundation to The University of Texas MD Anderson Cancer Center, Baylor College of Medicine and the Massachusetts Institute of Technology (MIT).

13 Sep 2012

Endocannabinoids may contribute to pregnancy complications

New research indicates marijuana-like compounds called endocannabinoids alter genes and biological signals critical to the formation of a normal placenta during pregnancy and may contribute to pregnancy complications like preeclampsia.

13 Sep 2012

Mayo Clinic ‘telestroke’ program will now be available at Casa Grande Regional Medical Center

Pinal County residents in need of emergency medical care for a stroke may benefit from a Mayo Clinic "telestroke" program that will now be available at Casa Grande Regional Medical Center (CGRMC).

13 Sep 2012

Sanofi Aventis receives FDA approval for Aubagio to treat relapsing forms of MS

The U.S. Food and Drug Administration today approved Aubagio (teriflunomide), a once-a-day tablet for the treatment of adults with relapsing forms of multiple sclerosis (MS).

13 Sep 2012

Genzyme receives FDA approval for AUBAGIO to treat relapsing forms of MS

Genzyme, a Sanofi company, announced today that the U.S. Food and Drug Administration (FDA) has approved AUBAGIO (teriflunomide) as a new once-daily, oral treatment indicated for patients with relapsing forms of multiple sclerosis (MS).

13 Sep 2012

Exercise may affect how people respond to food cues

It is commonly assumed that you can "work up an appetite" with a vigorous workout. Turns out that theory may not be completely accurate - at least immediately following exercise.

13 Sep 2012

Ageing in neurons follows same rules as in senescing fibroblasts

The ageing process has its roots deep within the cells and molecules that make up our bodies. Experts have previously identified the molecular pathway that react to cell damage and stems the cell's ability to divide, known as cell senescence.

12 Sep 2012

UB researchers receive NFL grant for sports-related medical research on concussion

After sustaining a concussion, when can an athlete safely return to play? That's the primary question for professional and amateur athletes alike. Now, University at Buffalo sports medicine researchers have been awarded $100,000 from NFL Charities to develop the most objective, scientific method of determining when an athlete who has had a concussion can safely return to play.

12 Sep 2012

Noisy environments cause ears of people with hearing impairments to work differently

The world continues to be a noisy place, and Purdue University researchers have found that all that background chatter causes the ears of those with hearing impairments to work differently.

12 Sep 2012

Weill Cornell to establish new child care center

Weill Cornell Medical College announced today that it will create a child care center for up to 60 children of its faculty, students and staff near its campus on the Upper East Side of Manhattan.

12 Sep 2012

Diet could avert toxic effects of quinine in patients with malaria

Scientists at The University of Nottingham say adverse side-effects caused by the anti-parasitic drug quinine in the treatment of malaria could be controlled by what we eat.

12 Sep 2012

Bioengineers design nanoparticles that can safely and predictably infiltrate deep into the brain

The brain is a notoriously difficult organ to treat, but Johns Hopkins researchers report they are one step closer to having a drug-delivery system flexible enough to overcome some key challenges posed by brain cancer and perhaps other maladies affecting that organ.

12 Sep 2012

e-Therapeutics initiates second ETS2101 phase I trial in solid tumours

e-Therapeutics plc announces that it has started a second phase I clinical trial of its anti-cancer drug ETS2101. This trial will enrol up to 45 patients with a variety of solid tumours at two UK centres, St James's University Hospital in Leeds and the Northern Centre for Cancer Care at the Freeman Hospital in Newcastle.

12 Sep 2012

'Deep sleep' intimately involved in complex control of pubertal onset

Slow-wave sleep, or 'deep sleep', is intimately involved in the complex control of the onset of puberty, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology and Metabolism (JCEM).

12 Sep 2012

Genes predict the brain's reaction to smoking

Have you ever wondered why some people find it so much easier to stop smoking than others? New research shows that vulnerability to smoking addiction is shaped by our genes. A study from the Montreal Neurological Institute and Hospital - The Neuro, McGill University shows that people with genetically fast nicotine metabolism have a significantly greater brain response to smoking cues than those with slow nicotine metabolism.

12 Sep 2012

Ginkgo biloba supplements fail to improve cognitive performance in multiple sclerosis

A research study conducted by Dr. Jesus Lovera, Assistant Professor of Neurology at LSU Health Sciences Center New Orleans, and colleagues has found that the herbal supplement Ginkgo biloba does not improve cognitive function in patients with Multiple Sclerosis (MS).

12 Sep 2012

Book provides holistic view of post-traumatic stress disorder

Close to 5.2 million adults experience post-traumatic stress disorder (PTSD) every year. And it can affect anyone — from war veterans and abuse victims to persons directly or indirectly traumatized by violence, natural disaster or other catastrophes.

12 Sep 2012

Serum-concentration of antioxidants is significantly lower in patients with mild dementia

Forgetfulness, lack of orientation, cognitive decline… about 700, 000 Germans suffer from Alzheimer's disease (AD). Now researchers from the University of Ulm, among them the Epidemiologist Professor Gabriele Nagel and the Neurologist Professor Christine von Arnim, have discovered that the serum-concentration of the antioxidants vitamin C and beta-carotene are significantly lower in patients with mild dementia than in control persons.

12 Sep 2012

Roundup: Mass. voters to consider 'right-to-die'; Texas Planned Parenthood hearing contentious; Calif. kids' palliative care

On Election Day, voters in the Bay State will consider whether to approve the "Death With Dignity Act," a measure that would make Massachusetts just the third state in the country to formally approve physician-assisted suicide. The proposal, identified as Question 2 on the ballot, is nearly identical to laws passed in Oregon in 1994 and in Washington in 2008. But the politics is very different. The looming vote has split the state's medical community and mobilized opposition from the politically powerful Catholic Church.

12 Sep 2012

Brain News and Research

Further Reading

ICREA researcher updates latest findings in applied epigenetics

NDC to advance study and treatment of Alzheimer's and other neurodegenerative diseases

Endocannabinoids may contribute to pregnancy complications

Mayo Clinic ‘telestroke’ program will now be available at Casa Grande Regional Medical Center

Sanofi Aventis receives FDA approval for Aubagio to treat relapsing forms of MS

Genzyme receives FDA approval for AUBAGIO to treat relapsing forms of MS

Exercise may affect how people respond to food cues

Ageing in neurons follows same rules as in senescing fibroblasts

UB researchers receive NFL grant for sports-related medical research on concussion

Noisy environments cause ears of people with hearing impairments to work differently

Weill Cornell to establish new child care center

Diet could avert toxic effects of quinine in patients with malaria

Bioengineers design nanoparticles that can safely and predictably infiltrate deep into the brain

e-Therapeutics initiates second ETS2101 phase I trial in solid tumours

'Deep sleep' intimately involved in complex control of pubertal onset

Genes predict the brain's reaction to smoking

Ginkgo biloba supplements fail to improve cognitive performance in multiple sclerosis

Book provides holistic view of post-traumatic stress disorder

Serum-concentration of antioxidants is significantly lower in patients with mild dementia

Roundup: Mass. voters to consider 'right-to-die'; Texas Planned Parenthood hearing contentious; Calif. kids' palliative care

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News